Ardsley Advisory Partners’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.7M Buy
+60,000
New +$10M 1.03% 33
2022
Q4
– Sell
-50,000
Closed -$5.48M – 122
2022
Q3
$5.48M Sell
50,000
-33,000
-40% -$4.19M 1.23% 27
2022
Q2
$11M Sell
83,000
-7,500
-8% -$984K 1.8% 14
2022
Q1
$12M Buy
90,500
+90,175
+27,746% +$10.8M 2% 12
2021
Q4
$38K Sell
325
-150,025
-100% -$17.7M 0.01% 105
2021
Q3
$18.1M Buy
150,350
+75,350
+100% +$8.77M 2.75% 9
2021
Q2
$8.98M Buy
+75,000
New +$8.23M 1.06% 26
2020
Q4
– Sell
-4,750
Closed -$521K – 139
2020
Q3
$521K Sell
4,750
-2,500
-34% -$278K 0.1% 95
2020
Q2
$767K Buy
+7,250
New +$749K 0.16% 68
2020
Q1
– Sell
-3,750
Closed -$374K – 107
2019
Q4
$374K Buy
+3,750
New +$353K 0.06% 111

Other funds holding AZN

Ardsley Advisory Partners's AZN Position: Q3 2026 in Review

Ardsley Advisory Partners opened a new position in AstraZeneca (AZN) in Q3 2026: 60,000 shares worth $9.7M. The stake represents 1.03% of the portfolio and ranks #33 among its holdings. This is a return to the name: Ardsley Advisory Partners previously reported a position in AZN as recently as Q3 2022.

Ardsley Advisory Partners first reported a position in AZN in Q4 2019 and has held it in 10 quarters since. The position peaked at $18.1M in Q3 2021. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Ardsley Advisory Partners held 60,000 shares of AstraZeneca worth $9.7M as of Q3 2026.
  • AstraZeneca was a new Ardsley Advisory Partners position in Q3 2026.
  • AstraZeneca made up 1.03% of Ardsley Advisory Partners's portfolio in Q3 2026, its #33 holding.
  • Ardsley Advisory Partners first reported a position in AstraZeneca in Q4 2019 and has held it in 10 quarters since.
  • Ardsley Advisory Partners's AstraZeneca position peaked at $18.1M in Q3 2021.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Ardsley Advisory Partners's 13F filing for Q3 2026, filed 16 Nov 2026.